Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/23617| Title: | Analysis of antipsychotic dose reduction |
| Authors: | Uchida, Hiroyuki Suzuki, Takefumi Takeuchi, Hiroyoshi Mamo, David |
| Keywords: | Antipsychotic drugs Schizophrenia -- Diagnosis |
| Issue Date: | 2010 |
| Publisher: | American Psychiatric Publishing, Inc. |
| Citation: | Uchida, H., Suzuki, T., Takeuchi, H., & Mamo, D. C. (2010). Analysis of antipsychotic dose reduction. American Journal of Psychiatry, 167(8), 994-994. |
| Abstract: | In the June 2010 issue of the Journal, Chuan-Yue Wang, M.D., Ph.D., et al. (1) conducted an open-label randomized controlled trial to examine the effects of reducing the risperidone dose in schizophrenia patients who had completed an acute phase treatment. The authors concluded that maintenance treatment at the initial dose for at least 1 year was safer and more effective in relapse prevention than the reduced dose strategy. |
| URI: | https://www.um.edu.mt/library/oar//handle/123456789/23617 |
| Appears in Collections: | Scholarly Works - FacM&SPsy |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Analysis_of_Antipsychotic_Dose_Reduction.pdf | 61.87 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.